TITLE

Coronary heart disease policy models: a systematic review

AUTHOR(S)
Unal, Belgin; Capewell, Simon; Critchley, Julia Alison
PUB. DATE
January 2006
SOURCE
BMC Public Health;2006, Vol. 6, p213
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The prevention and treatment of coronary heart disease (CHD) is complex. A variety of models have therefore been developed to try and explain past trends and predict future possibilities. The aim of this systematic review was to evaluate the strengths and limitations of existing CHD policy models. Methods: A search strategy was developed, piloted and run in MEDLINE and EMBASE electronic databases, supplemented by manually searching reference lists of relevant articles and reviews. Two reviewers independently checked the papers for inclusion and appraisal. All CHD modelling studies were included which addressed a defined population and reported on one or more key outcomes (deaths prevented, life years gained, mortality, incidence, prevalence, disability or cost of treatment). Results: In total, 75 articles describing 42 models were included; 12 (29%) of the 42 models were micro-simulation, 8 (19%) cell-based, and 8 (19%) life table analyses, while 14 (33%) used other modelling methods. Outcomes most commonly reported were cost-effectiveness (36%), numbers of deaths prevented (33%), life-years gained (23%) or CHD incidence (23%). Among the 42 models, 29 (69%) included one or more risk factors for primary prevention, while 8 (19%) just considered CHD treatments. Only 5 (12%) were comprehensive, considering both risk factors and treatments. The six best-developed models are summarised in this paper, all are considered in detail in the appendices. Conclusion: Existing CHD policy models vary widely in their depth, breadth, quality, utility and versatility. Few models have been calibrated against observed data, replicated in different settings or adequately validated. Before being accepted as a policy aid, any CHD model should provide an explicit statement of its aims, assumptions, outputs, strengths and limitations.
ACCESSION #
29362356

 

Related Articles

  • Experts debate using risk or expected benefit for determining when to start stain therapy.  // Formulary;Nov99, Vol. 34 Issue 11, p908 

    Presents perspectives on the use of statin therapy for primary prevention of coronary artery diseases. Initiation of statins for primary prevention guided by the risk of future cardiovascular events; Multifactorial approach to guide treatment decisions; Statin therapy guided by the expected...

  • Pets that heal.  // Consumer Reports on Health;Oct93, Vol. 5 Issue 10, p109 

    Suggests the role of pets in fighting coronary heart disease. Research from Purdue University showing lower blood pressure and cholesterol levels of pet owners; Quality of relationships with other people of pet owners; Alleviation of psychological and social factors.

  • Ticagrelor's efficacy outweighs generic clopidogrel's low price.  // PharmacoEconomics & Outcomes News;7/16/2011, Issue 633, p3 

    The article focuses on a study of the cost effectiveness of using ticagrelor in the secondary prevention of acute coronary syndromes (ACS) compared with clopidogrel treatment conducted by D. J. Crespin and colleagues and published in the June 2011 issue of "Value in Health."

  • Exercise, drug interventions may produce similar outcomes on mortality.  // Endocrine Today;Nov2013, Vol. 11 Issue 11, p16 

    The article discusses a study published in a 2013 issue of the "British Medical Journal" which found that exercise and drug interventions appear to have similar mortality benefits in the prevention of coronary heart disease and diabetes, rehabilitation after stroke and treatment of heart failure.

  • Should all postmenopausal women receive estrogen? No easy answers.  // Modern Medicine;Apr94, Vol. 62 Issue 4, p32 

    Discusses whether physicians should routinely prescribe estrogen for post-menopausal women to ward off coronary heart disease (CHD). Absence of randomized prospective trial to recommend estrogen for CHD; Lower risk of CHD among estrogen users.

  • Cardiovascular protection extends to women who use progestin with estrogen.  // Modern Medicine;Dec96, Vol. 64 Issue 12, p22 

    Discusses a study conducted by physician Francine Grodstein and colleagues which revealed that estrogen therapies that include progestin provide a degree of protection against heart disease that is similar to that of estrogen alone. Effectiveness of progestin and estrogen in lowering incidence...

  • Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011. Huber, Carola A.; Schwenkglenks, Matthias; Rapold, Roland; Reich, Oliver // BMC Endocrine Disorders;2014, Vol. 14 Issue 1, p19 

    Background Quantifying the burden of diabetes mellitus is fundamental for managing patients in health service delivery systems and improves the understanding of the importance of prevention and early intervention of diabetes. In Switzerland, epidemiological data on diabetes are very scarce. In...

  • Knowledge and Practice Assessment of Workers in a Pharmaceutical Company about Prevention of Coronary Artery Disease. Attarchi, Mirsaeed; Mohammadi, Saber; Nojomi, Marzieh; Labbafinejad, Yasser // Acta Medica Iranica;2012, Vol. 50 Issue 10, p697 

    Coronary artery disease is one of the most common reasons of death around the world. Also, according to previous studies, the incidence of coronary artery disease is rapidly increasing in developing countries such as Iran. The aim of this study was to evaluate the knowledge and practice of...

  • Full Medicare prescription coverage beneficial post-MI.  // PharmacoEconomics & Outcomes News;4/19/2008, Issue 551, p3 

    The article discusses research being done on the benefits of full Medicare drug coverage to post-myocardial infarction (MI) Medicare beneficiaries. It references a study by N. K. Choudry et al, published in the March 11, 2008 issue of "Circulation." It notes that full prescription coverage for...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics